|
Market Closed -
Toronto S.E.
16:00:00 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 5.010 CAD | -1.38% |
|
-1.76% | +72.16% |
| 08-11 | Medexus Pharmaceuticals Inc., Q1 2027 Earnings Call, Aug 11, 2026 | |
| 08-11 | Medexus Pharmaceuticals Fiscal Q1 Net Income, Revenue Rise Year-on-Year | MT |
| Market Cap | 157M 114M 97.99M 92.45M 84.22M 10.89B 159M 1.1B 424M 5.53B 428M 419M 17.55B | P/E 2027 * |
21.8x | P/E 2028 * | 6.05x |
|---|---|---|---|---|---|
| Enterprise Value | 157M 114M 97.99M 92.45M 84.22M 10.89B 159M 1.1B 424M 5.53B 428M 419M 17.55B | EV / Sales 2027 * |
0.96x | EV / Sales 2028 * | 0.8x |
| Free-Float |
93.53% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| MDP | Delayed | |
OTC Markets
| MEDXF | Delayed | |
|
Deutsche Boerse AG
| P731 | Delayed |
Last Transcript : Medexus Pharmaceuticals Inc.
| 1 day | -1.38% | ||
| 1 week | -1.76% | ||
| Current month | -4.39% | ||
| 1 month | +1.01% | ||
| 3 months | +25.25% | ||
| 6 months | +54.15% | ||
| Current year | +72.16% |
| 1 week | 4.6 |  | 5.12 |
| 1 month | 4.6 | | 5.5 |
| Current year | 2.65 | | 5.5 |
| 1 year | 2.51 | | 5.5 |
| 3 years | 1.44 | | 5.56 |
| 5 years | 0.88 | | 5.56 |
| 10 years | 0.88 | | 9.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2018-12-16 | |
Brendon Buschman
DFI | Director of Finance/CFO | - | 2019-05-31 |
| General Counsel | - | 2021-11-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mueller
CHM | Chairman | 66 | 2023-04-10 |
Benoit Gravel
BRD | Director/Board Member | - | 2017-09-21 |
| Director/Board Member | - | 2018-10-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/21/26 | Tax | Company | -1,000 | 0.0032% | - | |
| 8/21/26 | Tax | Company | 1,000 | 0.0032% | - | |
| 8/20/26 | Tax | Company | -8,100 | 0.0258% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.38% | -1.76% | +61.09% | +51.82% | 116M | |
| -0.11% | -3.16% | +48.82% | +91.49% | 1,002B | |
| -0.27% | -4.34% | +51.52% | +65.89% | 644B | |
| +1.63% | -2.00% | +20.49% | +71.12% | 443B | |
| -0.63% | -3.09% | +29.84% | +34.59% | 343B | |
| +0.43% | -14.61% | +11.32% | +27.26% | 262B | |
| +0.93% | -3.19% | -1.31% | +8.41% | 245B | |
| -2.25% | -13.88% | +37.33% | +47.43% | 212B | |
| -0.90% | -5.06% | -18.47% | -57.75% | 199B | |
| -0.58% | -4.24% | +25.65% | +90.54% | 181B | |
| Average | -0.24% | -4.95% | +26.63% | +43.08% | 352.98B | |
| Weighted average by Cap. | +0.07% | -4.39% | +31.99% | +57.11% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 163M 118M 102M 95.81M 87.28M 11.29B 165M 1.14B 439M 5.73B 443M 434M 18.19B | 197M 142M 122M 115M 105M 13.6B 198M 1.37B 529M 6.9B 534M 522M 21.91B |
| Net income | 7.47M 5.4M 4.65M 4.39M 3.99M 517M 7.54M 52.23M 20.1M 262M 20.29M 19.85M 832M | 26.89M 19.46M 16.74M 15.79M 14.39M 1.86B 27.14M 188M 72.38M 944M 73.08M 71.48M 3B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | $5.010 | -1.38% | 50,840 |
| 26-09-09 | $5.080 | 0.00% | 41,383 |
| 26-09-08 | $5.080 | +0.40% | 46,886 |
| 26-09-04 | $5.060 | -0.78% | 16,829 |
| 26-09-03 | $5.100 | -2.49% | 39,377 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDP Stock
Select your edition
All financial news and data tailored to specific country editions
